Sun Pharmaceutical Industries Ltd (SUNPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 948699, "name": "Sun Pharma.Inds.", "stock_name": "Sun Pharma.Inds.", "full_name": "Sun Pharmaceutical Industries Ltd", "name_url": "stocks-analysis/sun-pharmainds", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,862.80", "chg": -11.6, "chgp": "-0.62%", "dir": -1, "prev_price": "1,874.40", "mcapval": "449,743.00 Cr", "mcap": "Large Cap", "scripcode": 524715, "symbol": "SUNPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE044A01036", "curr_date": "Jun 25, 03:30 PM", "curr_time": "16:24 PM", "last_traded_at": "Jun 25, 03:30 PM IST", "bse_nse_vol": "19.9 lacs", "exc_status": "Active", "traded_date": "Jun 25, 2026", "traded_date_str": "2026 06 25", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-1&utm_source=Spage_Header_Score", "mojoone": { "text": "Part of MojoOne Strategy", "type": "MS", "url": "https://www.marketsmojo.com/mojostocks#!#top10", "ismore": 0, "all_data": [], "is_blur": 1, "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-1&utm_source=Spage_Score_PartofStrategies" } }, "news": { "results": [ { "title": "Sun Pharmaceutical Industries Sees Sharp Open Interest Surge Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-sharp-open-interest-surge-amid-mixed-market-signals-4073593", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SunPharmaceutic_oi_spurts_by_underlying_4073593.png", "date": "2026-06-25 15:01:03", "description": "Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable 11.02% increase in open interest in its derivatives segment, signalling heightened market activity and evolving positioning among traders. Despite a marginal dip in the stock price, the surge in open interest alongside robust volume patterns suggests a complex interplay of directional bets and investor sentiment within the Pharmaceuticals & Biotechnology sector." }, { "title": "P/E at 36.02 vs Industry's 34.66: What the Data Shows for Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-sustained-momentum-reinforces-nifty-50-status-4072705", "imagepath": "", "date": "2026-06-25 09:21:38", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <p><strong>Valuation Picture: Premium Amidst Sector Norms</strong></p>\n <p>The stock’s P/E ratio of 36.02 represents a modest premium of approximately 3.9% over the industry average of 34.66. This premium suggests that the market is pricing in a degree of growth or stability above the sector norm. However, the differential is not excessively stretched, indicating that valuation remains within a reasonable range relative to peers. The sector’s average P/E reflects a broad spectrum of companies, with some trading at significant discounts or premiums, so <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"ctx\">what is the current rating?</a> for a stock with this valuation profile?</p>\n\n <p><strong>Performance Across Timeframe..." }, { "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Positioning", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-bullish-market-positioning-4070727", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SunPharmaceutic_oi_spurts_by_underlying_4070727.png", "date": "2026-06-24 15:00:48", "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock, trading close to its 52-week high, has demonstrated sustained gains over the past week, supported by rising volumes and improving investor sentiment." }, { "title": "P/E at 35.95 vs Industry's 34.68: What the Data Shows for Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-amid-nifty-50-membership-and-institutional-interest-4069928", "imagepath": "", "date": "2026-06-24 09:21:28", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <p><strong>Valuation Picture: Premium but Not Excessive</strong></p>\n <p>The P/E ratio of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> at 35.95 represents a modest premium of approximately 3.6% over the industry average of 34.68. This premium suggests that the market attributes slightly higher growth expectations or better earnings quality to the company compared to its peers. However, the gap is not wide enough to indicate an extreme overvaluation scenario. The sector itself is characterised by a broad range of valuations, with some companies trading at significantly higher multiples due to niche product portfolios or strong pipeline prospects.</p>\n <p>Given the premium, <a..." }, { "title": "10,956 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Nears Rs 1,900 Strike", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-amid-bullish-momentum-4068756", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SunPharmaceutic_most_active_stocks_calls_4068756.png", "date": "2026-06-23 10:00:15", "description": "On 23 Jun 2026, 10,956 call contracts at the Rs 1,900 strike price changed hands on Sun Pharmaceutical Industries Ltd, with the stock closing at Rs 1,892. This near at-the-money activity coincides with a 1.80% gain in the cash market, signalling a strong alignment between options positioning and underlying price momentum." }, { "title": "Rs 1,840 Puts — 2.7% Below Current Price — Draw 2,530 Contracts on Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-heavy-put-option-activity-amid-mixed-market-signals-4068763", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SunPharmaceutic_most_active_stocks_puts_4068763.png", "date": "2026-06-23 10:00:15", "description": "The stock is trading at Rs 1,892, yet put contracts at the Rs 1,840 strike have surged to 2,530 on 23 Jun 2026, signalling a nuanced options market dynamic for Sun Pharmaceutical Industries Ltd. This activity invites a closer look at whether these puts represent hedging, bearish bets, or put writing." }, { "title": "P/E at 35.85 vs Industry's 34.38: What the Data Shows for Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-a-key-nifty-50-constituent-4068545", "imagepath": "", "date": "2026-06-23 09:21:20", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <p><strong>Valuation Picture: Premium Amidst Sector Parity</strong></p>\n <p>The current P/E of 35.85 for <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> represents a modest premium of approximately 4.3% over the sector average of 34.38. This premium suggests that investors are willing to pay slightly more for the company’s earnings relative to its peers in Pharmaceuticals & Biotechnology. Given the sector’s broad composition, which includes 35 stocks with 19 reporting positive results, 9 flat, and 7 negative, this premium may reflect confidence in the company’s earnings stability and growth prospects. However, the premium is not excessive, indicating a valuation that remains broadly in li..." }, { "title": "P/E at 35.38 vs Industry's 34.06: What the Data Shows for Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-navigating-nifty-50-membership-and-institutional-dynamics-4066834", "imagepath": "", "date": "2026-06-22 09:21:42", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <p><strong>Valuation Picture: Premium Amidst Sector Parity</strong></p>\n <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 35.38, slightly above the Pharmaceuticals & Biotechnology industry average of 34.06. This premium, though not extreme, suggests investors are willing to pay a bit more for the stock relative to its peers. The market capitalisation of ₹4,40,086.02 crore places it firmly in the large-cap category, reflecting its established position within the sector.</p>\n <p>This valuation premium may be interpreted as a reflection of the company’s relative stability and growth prospects within a sector that has seen varied results. However,..." }, { "title": "Sun Pharmaceutical Industries Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-ltd-is-rated-buy-4066060", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/SunPharmaceutic_mojoScore_4066060.png", "date": "2026-06-21 10:10:26", "description": "Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 8 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 June 2026, providing investors with the latest insights into the company’s performance and outlook." } ], "total": 1158, "sid": "948699", "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699" }, "announcements": [ { "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding Intimation under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015", "source": "NSE", "caption": "Sun Pharmaceutical Industries Limited - Other General Purpose", "datetime": "09-Dec-2019" }, { "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated November 06, 2019, titled \"Sun Pharma and AstraZeneca enter into License Agreement for Novel Oncology products in China\".", "source": "NSE", "caption": "Sun Pharmaceutical Industries Limited - Press Release", "datetime": "06-Nov-2019" }, { "details": "Sun Pharmaceutical Industries Limited has informed the Exchange regarding 'Please find enclosed Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018'.", "source": "NSE", "caption": "Sun Pharmaceutical Industries Limited - Updates", "datetime": "18-Oct-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>500%</strong> dividend, ex-date: 07 Jul 26", "dt": "2026-07-07", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10", "dt": "2010-11-25", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13", "dt": "2013-07-29", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Valuation Picture: Premium Amidst Sector Norms

The stock’s P/E ratio of 36.02 represents a modest premium of approximately 3.9% over the industry average of 34.66. This premium suggests that the market is pricing in a degree of growth or stability above the sector norm. However, the differential is not excessively stretched, indicating that valuation remains within a reasonable range relative to peers. The sector’s average P/E reflects a broad spectrum of companies, with some trading at significant discounts or premiums, so what is the current rating? for a stock with this valuation profile?

Performance Across Timeframe...

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Positioning
2026-06-24 15:00:48
Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock, trading close to its 52-week high, has demonstrated sustained gains over the past week, supported by rising volumes and improving investor sentiment.
Read full news article

P/E at 35.95 vs Industry's 34.68: What the Data Shows for Sun Pharmaceutical Industries Ltd
2026-06-24 09:21:28

Valuation Picture: Premium but Not Excessive

The P/E ratio of Sun Pharmaceutical Industries Ltd at 35.95 represents a modest premium of approximately 3.6% over the industry average of 34.68. This premium suggests that the market attributes slightly higher growth expectations or better earnings quality to the company compared to its peers. However, the gap is not wide enough to indicate an extreme overvaluation scenario. The sector itself is characterised by a broad range of valuations, with some companies trading at significantly higher multiples due to niche product portfolios or strong pipeline prospects.

Given the premium, Read full news article
10,956 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Nears Rs 1,900 Strike
2026-06-23 10:00:15
On 23 Jun 2026, 10,956 call contracts at the Rs 1,900 strike price changed hands on Sun Pharmaceutical Industries Ltd, with the stock closing at Rs 1,892. This near at-the-money activity coincides with a 1.80% gain in the cash market, signalling a strong alignment between options positioning and underlying price momentum.
Read full news article
Rs 1,840 Puts — 2.7% Below Current Price — Draw 2,530 Contracts on Sun Pharmaceutical Industries Ltd
2026-06-23 10:00:15
The stock is trading at Rs 1,892, yet put contracts at the Rs 1,840 strike have surged to 2,530 on 23 Jun 2026, signalling a nuanced options market dynamic for Sun Pharmaceutical Industries Ltd. This activity invites a closer look at whether these puts represent hedging, bearish bets, or put writing.
Read full news article
P/E at 35.85 vs Industry's 34.38: What the Data Shows for Sun Pharmaceutical Industries Ltd
2026-06-23 09:21:20

Valuation Picture: Premium Amidst Sector Parity

The current P/E of 35.85 for Sun Pharmaceutical Industries Ltd represents a modest premium of approximately 4.3% over the sector average of 34.38. This premium suggests that investors are willing to pay slightly more for the company’s earnings relative to its peers in Pharmaceuticals & Biotechnology. Given the sector’s broad composition, which includes 35 stocks with 19 reporting positive results, 9 flat, and 7 negative, this premium may reflect confidence in the company’s earnings stability and growth prospects. However, the premium is not excessive, indicating a valuation that remains broadly in li...
Read full news article
P/E at 35.38 vs Industry's 34.06: What the Data Shows for Sun Pharmaceutical Industries Ltd
2026-06-22 09:21:42

Valuation Picture: Premium Amidst Sector Parity

The current P/E of Sun Pharmaceutical Industries Ltd stands at 35.38, slightly above the Pharmaceuticals & Biotechnology industry average of 34.06. This premium, though not extreme, suggests investors are willing to pay a bit more for the stock relative to its peers. The market capitalisation of ₹4,40,086.02 crore places it firmly in the large-cap category, reflecting its established position within the sector.

This valuation premium may be interpreted as a reflection of the company’s relative stability and growth prospects within a sector that has seen varied results. However,...
Read full news article
Sun Pharmaceutical Industries Ltd is Rated Buy
2026-06-21 10:10:26
Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 8 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
View All News